NASDAQ : CRNX

Crinetics Pharmaceuticals, Inc. — Stock Grades

$83.52 USD

-$0.11 (-0.13%)

Volume
1.86M
Average Volume
3.69M
Market Capitalization
$8.84B
P/E Ratio
-16.25
Dividend Yield
0.00%
Price Target
$85.00
Year High
$84.00
Year Low
$25.83
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$18.60
CRNX Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-07-28 UBS Buy Neutral Downgrade
2026-07-08 TD Cowen Buy Hold Downgrade
2026-07-08 Evercore ISI Group Outperform In Line Downgrade
2026-07-07 Cantor Fitzgerald Overweight Neutral Downgrade
2026-07-07 HC Wainwright & Co. Buy Neutral Downgrade
2026-07-07 Jones Trading Buy Hold Downgrade
2026-07-07 Jefferies Buy Hold Downgrade
2026-07-07 Oppenheimer Outperform Perform Downgrade
2026-07-07 Baird Outperform Outperform Maintain
2026-06-15 HC Wainwright & Co. Buy Buy Maintain
2026-06-11 Citizens Market Outperform Market Outperform Maintain
2026-05-15 Evercore ISI Group Outperform Outperform Maintain
2026-05-11 Oppenheimer Outperform Outperform Maintain
2026-05-08 Citizens Market Outperform Market Outperform Maintain
2026-04-28 Citizens Market Outperform Market Outperform Maintain
2026-03-02 Citizens Market Outperform Market Outperform Maintain
2026-01-12 Goldman Sachs Neutral Buy Upgrade
2026-01-08 Citizens Market Outperform Market Outperform Maintain
2026-01-06 Morgan Stanley Overweight Overweight Maintain